Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
49.00B
Market cap49.00B
Price-Earnings ratio
46.59
Price-Earnings ratio46.59
Dividend yield
Dividend yield
Average volume
5.38M
Average volume5.38M
High today
$86.49
High today$86.49
Low today
$83.17
Low today$83.17
Open price
$86.49
Open price$86.49
Volume
4.55M
Volume4.55M
52 Week high
$89.48
52 Week high$89.48
52 Week low
$72.30
52 Week low$72.30

Stock Snapshot

The current Edwards Lifesciences(EW) stock price is $85.18, with a market capitalization of 49B. The stock trades at a price-to-earnings (P/E) ratio of 46.59.

During the trading session on 2026-06-12, Edwards Lifesciences(EW) shares reached a daily high of $86.49 and a low of $83.17. At a current price of $85.18, the stock is +2.4% higher than the low and still -1.5% under the high.

Trading activity shows a volume of 4.55M, compared to an average daily volume of 5.38M.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $89.48 and a low of $72.30.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $89.48 and a low of $72.30.

EW News

Nasdaq 13h
Should You Continue to Hold EW Stock in Your Portfolio?

Edwards Lifesciences Corporation EW is well-poised to grow in the coming quarters owing to its Surgical Structural Heart, which pioneered the RESILIA tissue. Th...

Should You Continue to Hold EW Stock in Your Portfolio?
MarketWatch 2d
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch

...

Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch
TipRanks 2d
Edwards Lifesciences’ HPI Care Trial Posts Results, Offering Fresh Signals for Predictive Monitoring Investors

Edwards Lifesciences Corp. (EW) announced an update on their ongoing clinical study. The HPI Care Trial, officially titled “A Randomized Trial of the Hypotensi...

Analyst ratings

76%

of 33 ratings
Buy
75.8%
Hold
24.2%
Sell
0%

More EW News

Simply Wall St 5d
Did Higher 2026 TAVR Guidance and Autus Deal Just Shift Edwards Lifesciences' Investment Narrative?

Edwards Lifesciences recently raised its full-year 2026 sales and TAVR growth guidance and completed the acquisition of Autus Valve Technologies, further expand...

Did Higher 2026 TAVR Guidance and Autus Deal Just Shift Edwards Lifesciences' Investment Narrative?

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.